[ad_1]
Phibro Animal Health Corporation will create a biotechnology plant producing a range of animal health vaccines in the IDA Ireland Finisklin Industrial Park in Sligo, creating up to 150 jobs over five years.
The project is supported by the Irish government by IDA Ireland
Phibro develops, manufactures and markets a wide range of animal health and nutrition products for poultry, pork, livestock, dairy customers and aquaculture around the world. The company had annual sales of $ 764 million in more than 65 countries in its last fiscal year and employs more than 1,400 people worldwide.
Phibro is a publicly traded company headquartered in Teaneck, New Jersey, United States.
The Sligo plant will be the first organic manufacturing site in Europe and will allow Phibro to expand its presence in Europe. New Factory
The new manufacturing plant will initially focus on the production of Phibro's innovative line of vaccines for the treatment of a range of poultry diseases intended for sale in the world. In the future, Phibro plans to expand production to include vaccines for livestock and aquaculture.
Speaking at the announcement Thursday in Sligo, the Minister of Agriculture, Food and Marine, Michael Creed, said: a large vote of confidence in Sligo and will offer even more opportunities for residents and local communities to grow and prosper.
"It strengthens Ireland's capacity in the life sciences field in the North West and builds on a series of recently announced IDA new projects for Sligo and elsewhere in the region, the main cities, and this new biotech facility in Sligo is proof that the policy works, "said Jack Bendheim, president, president and CEO of Phibro, pointing out that the creation of Phibro Ireland marks an important step. "The winning combination of Phibro's expertise in the development and manufacture of organic products, the motivated and experienced workforce available in the Sligo area, and the strong support of the company. IDA makes us very excited about the potential of Sligo's installation. "
[ad_2]
Source link
